From conclave to collaboration – Team #CLINEXEL is ready to drive vaccine innovation forward.

India is the largest supplier of vaccines globally, contributing nearly 70% of the world’s vaccine supply and holding a significant number of WHO-prequalified vaccines.
Yet, what we truly need are innovative vaccines for diseases that continue to cause high morbidity and mortality in India – such as Dengue, Malaria, and Tuberculosis. Developing these requires:

✅ Strong science
✅ Efficient clinical development & operations
✅ Deep understanding of Indian & global regulations
At CLINEXEL, we are delighted to have participated in the Vaccine India Conclave and are committed to supporting the development of next-generation vaccines through our expertise in clinical trials and clinical development – both in India and globally.

We look forward to meaningful collaborations that drive innovation and improve public health outcomes. Write to us at info@clinexel.com for services.